Metsera, Inc.

Metsera, Inc. is a clinical-stage biopharmaceutical company specializing in the development of next-generation injectable and oral nutrient-stimulated hormone (NuSH) therapies for obesity and related metabolic diseases. Its portfolio targets improved effectiveness, tolerability, and scalability, aiming to address the evolving needs of the weight loss treatment market. Metsera is recognized for its integrated approach spanning peptide engineering, clinical development, and large-scale manufacturing.

Company Facts

• Headquarters: New York, United States
• Founded: 2022
• Employees: 5,000
• Type: Public Corporation
• Website: https://metsera.com
• Industries: Biotechnology, Pharmaceuticals, Healthcare, Obesity Treatment, Metabolic Diseases